Cargando…

P11: IXAZOMIB WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MYELOMA: MUKEIGHT PHASE II RANDOMISED CONTROLLED TRIAL RESULTS

Detalles Bibliográficos
Autores principales: Auner, H, Brown, S, Walker, K, Kendall, J, Dawkins, B, Meads, D, Morgan, G, Kaiser, M, Cook, M, Roberts, S, Parrish, C, Cook, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009795/
http://dx.doi.org/10.1097/01.HS9.0000829616.80742.a1
_version_ 1784687341264175104
author Auner, H
Brown, S
Walker, K
Kendall, J
Dawkins, B
Meads, D
Morgan, G
Kaiser, M
Cook, M
Roberts, S
Parrish, C
Cook, G
author_facet Auner, H
Brown, S
Walker, K
Kendall, J
Dawkins, B
Meads, D
Morgan, G
Kaiser, M
Cook, M
Roberts, S
Parrish, C
Cook, G
author_sort Auner, H
collection PubMed
description
format Online
Article
Text
id pubmed-9009795
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-90097952022-04-18 P11: IXAZOMIB WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MYELOMA: MUKEIGHT PHASE II RANDOMISED CONTROLLED TRIAL RESULTS Auner, H Brown, S Walker, K Kendall, J Dawkins, B Meads, D Morgan, G Kaiser, M Cook, M Roberts, S Parrish, C Cook, G Hemasphere Poster Lippincott Williams & Wilkins 2022-04-05 /pmc/articles/PMC9009795/ http://dx.doi.org/10.1097/01.HS9.0000829616.80742.a1 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Poster
Auner, H
Brown, S
Walker, K
Kendall, J
Dawkins, B
Meads, D
Morgan, G
Kaiser, M
Cook, M
Roberts, S
Parrish, C
Cook, G
P11: IXAZOMIB WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MYELOMA: MUKEIGHT PHASE II RANDOMISED CONTROLLED TRIAL RESULTS
title P11: IXAZOMIB WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MYELOMA: MUKEIGHT PHASE II RANDOMISED CONTROLLED TRIAL RESULTS
title_full P11: IXAZOMIB WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MYELOMA: MUKEIGHT PHASE II RANDOMISED CONTROLLED TRIAL RESULTS
title_fullStr P11: IXAZOMIB WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MYELOMA: MUKEIGHT PHASE II RANDOMISED CONTROLLED TRIAL RESULTS
title_full_unstemmed P11: IXAZOMIB WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MYELOMA: MUKEIGHT PHASE II RANDOMISED CONTROLLED TRIAL RESULTS
title_short P11: IXAZOMIB WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MYELOMA: MUKEIGHT PHASE II RANDOMISED CONTROLLED TRIAL RESULTS
title_sort p11: ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: mukeight phase ii randomised controlled trial results
topic Poster
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009795/
http://dx.doi.org/10.1097/01.HS9.0000829616.80742.a1
work_keys_str_mv AT aunerh p11ixazomibwithcyclophosphamideanddexamethasoneinrelapsedorrefractorymyelomamukeightphaseiirandomisedcontrolledtrialresults
AT browns p11ixazomibwithcyclophosphamideanddexamethasoneinrelapsedorrefractorymyelomamukeightphaseiirandomisedcontrolledtrialresults
AT walkerk p11ixazomibwithcyclophosphamideanddexamethasoneinrelapsedorrefractorymyelomamukeightphaseiirandomisedcontrolledtrialresults
AT kendallj p11ixazomibwithcyclophosphamideanddexamethasoneinrelapsedorrefractorymyelomamukeightphaseiirandomisedcontrolledtrialresults
AT dawkinsb p11ixazomibwithcyclophosphamideanddexamethasoneinrelapsedorrefractorymyelomamukeightphaseiirandomisedcontrolledtrialresults
AT meadsd p11ixazomibwithcyclophosphamideanddexamethasoneinrelapsedorrefractorymyelomamukeightphaseiirandomisedcontrolledtrialresults
AT morgang p11ixazomibwithcyclophosphamideanddexamethasoneinrelapsedorrefractorymyelomamukeightphaseiirandomisedcontrolledtrialresults
AT kaiserm p11ixazomibwithcyclophosphamideanddexamethasoneinrelapsedorrefractorymyelomamukeightphaseiirandomisedcontrolledtrialresults
AT cookm p11ixazomibwithcyclophosphamideanddexamethasoneinrelapsedorrefractorymyelomamukeightphaseiirandomisedcontrolledtrialresults
AT robertss p11ixazomibwithcyclophosphamideanddexamethasoneinrelapsedorrefractorymyelomamukeightphaseiirandomisedcontrolledtrialresults
AT parrishc p11ixazomibwithcyclophosphamideanddexamethasoneinrelapsedorrefractorymyelomamukeightphaseiirandomisedcontrolledtrialresults
AT cookg p11ixazomibwithcyclophosphamideanddexamethasoneinrelapsedorrefractorymyelomamukeightphaseiirandomisedcontrolledtrialresults